Benjamin F. Mcgraw III - Feb 28, 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role: Interim Executive Chair, Director
Signature: /s/ John LaRocca, Attorney-in-Fact for Benjamin F. McGraw
Stock symbol: AERI
Transactions as of: Feb 28, 2022
Transactions value $: -$85,689
Form type: 4
Date filed: 3/2/2022, 04:38 PM
Previous filing: Sep 22, 2021
Next filing: Jun 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AERI	Common Stock	Tax liability	-$85.7K	-10.3K	-22.41%	$8.30	35.7K	Feb 28, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.

Remarks:

Reported transaction occurred on February 28, 2022, after which date the reporting person ceased to serve in the position of Interim Executive Chair. The reporting person continues to serve as a director as of the date of this filing.